San Chung, Taiwan

Yo-Chin Liu

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Taigen Biotechnology Company, Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yo-Chin Liu. Retrieved from https://idiyas.com/inventor/yo-chin-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yo-Chin Liu

Introduction

Yo-Chin Liu is a notable inventor based in Sanchong, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for viral infections. His work has the potential to impact the lives of many individuals suffering from hepatitis C.

Latest Patents

Yo-Chin Liu holds 1 patent related to HCV protease inhibitors. This invention involves macrocyclic compounds of formula (I), which are designed to treat hepatitis C virus infections. The innovative nature of this patent highlights Liu's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Liu is currently associated with Taigen Biotechnology Company, Ltd., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Liu's coworkers include Chen-Fu Liu and Kuang-Yuan Lee. Their collaboration fosters a dynamic environment for innovation and research, contributing to the overall success of their projects.

Conclusion

In summary, Yo-Chin Liu is a dedicated inventor whose work in developing HCV protease inhibitors showcases his innovative spirit and commitment to improving healthcare. His contributions to biotechnology are invaluable and continue to pave the way for future advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…